Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer

Details for Australian Patent Application No. 2006269492 (hide)

Owner Kanisa Pharmaceuticals, Inc.

Inventors Socks, David; Glenn, Scott; Marcelletti, John; Walsh, Michael J.; Sikic, Branimir; Multani, Pratik S.; Hoth, Daniel

Agent Davies Collison Cave

Pub. Number AU-A-2006269492

PCT Pub. Number WO2007/008490

Priority 11/416,829 03.05.06 US; 11/416,571 03.05.06 US; 60/696,930 06.07.05 US; 11/416,832 03.05.06 US

Filing date 30 June 2006

Wipo publication date 18 January 2007

International Classifications

A61K 31/704 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4745 (2006.01)

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/008490 Priority application(s): WO2007/008490

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006269494-Processing collocation mistakes in documents

2006269490-Stable quantitation and detection of immune response levels with non-zero background peptides